Short answer
LEMAITRE VASCULAR INC (LMAT) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q-period earnings disclosure: full financial results and commentary contained in the referenced press release exhibit (Exhibit 99.1).
LEMAITRE VASCULAR INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q-period earnings disclosure: full financial results and commentary contained in the referenced press release exhibit (Exhibit 99.1)
- LMAT is a vascular surgery device company; earnings reports typically cover revenue, gross margin, and guidance updates material to investors
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LEMAITRE VASCULAR INC 8-K filings
Get the next LMAT 8-K as it lands
Follow LMAT for push alerts, or ask the research agent what this filing means.